It is the capex number that is the problem. This is going to take some time to build and to finance currently an arduous task
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ASX Market Open: Powell hope to power Santa rally through French gov't collapse, South Korean crisis | Dec 5, 2024